Nicotine Transdermal System (Nicotine Transdermal System) (PATCH) 14 mg/24h

Nicotine transdermal system 14 mg/24h patch helps reduce cravings and withdrawal symptoms during smoking cessation. This nicotine replacement therapy delivers steady nicotine doses through the skin. Ideal for adults seeking to quit tobacco use.

Strength

14 mg/24h

Manufacturer / TM Owner

H-E-B

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nicotine transdermal system 14 mg/24h is used to help people stop smoking by reducing nicotine withdrawal symptoms. It provides controlled nicotine doses through the skin to ease cravings during the quitting process. This therapy supports gradual reduction of dependence on tobacco products.

Side Effects

Users may experience reduced cigarette cravings and irritability when using the nicotine transdermal system. Some people notice improved mood stability and concentration during the transition away from smoking. Skin irritation at the patch site is a common effect.

Precautions & Warnings

Keep nicotine transdermal patches out of reach of children and pets to prevent accidental exposure. Avoid using patches on damaged or irritated skin to reduce irritation risk. Do not cut or alter patches as this may affect nicotine delivery.

Avoid Interactions

Nicotine transdermal system may interact with other nicotine products, increasing side effects like nausea or dizziness. Combining with certain medications, such as stimulants or asthma treatments, may require medical supervision. Alcohol use may enhance nicotine effects.

Frequently Asked Questions

It helps reduce cravings and withdrawal symptoms when quitting smoking by delivering controlled nicotine doses through the skin.

Follow your healthcare provider's instructions; patches are typically worn for 16–24 hours depending on the prescribed schedule.

Consult a healthcare professional before using nicotine replacement therapy during pregnancy.

Common effects include skin irritation, dizziness, and mild nausea. Severe reactions should be reported to a doctor.

Store patches in a cool, dry place away from children and pets. Do not expose to direct heat or sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.